Dutasteride 0.5 mg and Silodosin 8 mg Capsule

Uses of Dutasteride 0.5 mg and Silodosin 8 mg Capsule

This medication is primarily used in adult men to treat the symptoms of an enlarged prostate, which may include difficulty in starting the flow of urine, weak stream, and the need to urinate frequently or urgently. It is not intended for use in women or children.

Benefits of Dutasteride 0.5 mg and Silodosin 8 mg Capsule

• Reduces the size of the enlarged prostate over time, potentially avoiding the need for surgery.
• Improves urinary flow and reduces the symptoms of BPH.
• Can decrease the likelihood of acute urinary retention.
• Offers a convenient once-daily dosing regimen.

Side Effects of Dutasteride 0.5 mg and Silodosin 8 mg Capsule

While most people do not experience severe side effects, some common ones may include:

• Decreased libido
• Ejaculation disorders
• Dizziness
• Breast tenderness or enlargement

Please consult a healthcare provider if you experience persistent side effects or any signs of allergic reaction.

How to Use Dutasteride 0.5 mg and Silodosin 8 mg Capsule

• Take this medication as prescribed by your doctor, usually once a day with or without food.
• Swallow the capsule whole, without crushing or chewing, to avoid exposure to a potentially irritating substance.

How Dutasteride 0.5 mg and Silodosin 8 mg Capsule Works

Dutasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT), a hormone involved in prostate growth. Silodosin relaxes the muscles in the prostate and bladder neck, making it easier to urinate. Together, these actions help to relieve the symptoms of BPH.

Storage

Store the capsules at room temperature, away from light and moisture. Keep out of reach of children and pets.

Caution and Warning

• Not for use in women, children, or patients with severe liver disease.
• May interact with other medications; disclose all medications you are taking to your healthcare provider.
• Pregnant women should avoid handling the capsules due to the potential for absorption of Dutasteride and the subsequent risk to a male fetus.
• Regular monitoring by a healthcare provider is recommended to assess the effectiveness and safety of the treatment.